The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

Rexahn Pharmaceuticals Inc. / See Company Profile

Alliance / BioSense Global to develop and sell Rexahn's RX3117 in Greater China / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 17, 2019

Financing / Public stock sale nets $8mm for Rexahn / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Feb. 9, 2019

Financing / Registered direct offering nets $7mm for Rexahn / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 23, 2018

Fibrocell Science Inc. / See Company Profile

Alliance / Castle Creek licenses US rights to Fibrocell's FCX007 RDEB gene therapy candidate for up to $135mm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 17, 2019

Financing / Fibrocell brings in $9.9mm through FOPO / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 19, 2017

Financing / Fibrocell nets $7.7mm through PIPE / Strategic Transactions / Deal Date: Mar. 1, 2017 / Publish Date: Mar. 14, 2017

PureTech Health PLC / See Company Profile

Alliance / BI, PureTech collaborate on I/O candidates in $226mm tie-up / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 18, 2019

Financing / Karuna brings in $68mm through its Series B round / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 19, 2019

Alliance / Purdue licenses Alivio's ALV107 for IC/BPS pain / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 31, 2019

IFM Tre / See Company Profile

Financing / IFM Tre launches with $31mm Series A round / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Apr. 4, 2019

Acquisition / Novartis acquires NLRP3 inflammasome-focused IFM Tre for up to $1.58bn / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 3, 2019


Medical Devices

Email Alert | RSS Feed

Cerus Corp. / See Company Profile

Financing / Cerus signs debt facility for up to $90mm; $40mm drawn at closing / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 4, 2019

Financing / Cerus nets $57.2mm through public offering / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Feb. 3, 2018

Financing / Cerus receives $10mm debt financing from Oxford, amended / Strategic Transactions / Deal Date: Jul. 1, 2014 / Update Date: Aug. 1, 2017

Lantheus Holdings Inc. / See Company Profile

Alliance / Cerevast, Lantheus sign deal for retinal vein occlusion device / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 4, 2019

Alliance / Lantheus Medical, GE Healthcare enter preliminary agreement for PET cardiac imaging agent; deal finalized / Strategic Transactions / Deal Date: Feb. 1, 2017 / Update Date: Apr. 1, 2017

Financing / Lantheus Holdings nets $39.9mm via FOPO / Strategic Transactions / Deal Date: Sep. 1, 2016 / Publish Date: Sep. 22, 2016

PolarityTE Inc. / See Company Profile

Financing / Public offering brings in $24.9mm for PolarityTE / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 12, 2019

Financing / Latest follow-on grosses $58mm for PolarityTE / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 7, 2018

Financing / PolarityTE nets $35mm through public offering / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 16, 2018

Intrinsic Therapeutics Inc. / See Company Profile

Financing / Intrinsic raises $52mm via late-stage financing / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 15, 2019

Financing / Intrinsic closes financing of equity and debt / Strategic Transactions / Deal Date: May 1, 2017 / Publish Date: May 30, 2017

Financing / Intrinsic Therapeutics lands $12.25mm in late-stage round / Strategic Transactions / Deal Date: Oct. 1, 2012 / Publish Date: Nov. 26, 2012


In Vitro Diagnostics

Email Alert | RSS Feed

Natera Inc. / See Company Profile

Financing / Public offering nets Natera $94mm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 22, 2019

Alliance / Natera to launch Signatera test in China on BGI's DNBseq NGS platform / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 12, 2019

Financing / Natera nets $84.6mm through FOPO / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 13, 2018

OncoTracker Inc. / See Company Profile

Alliance / OncoTracker licenses key patents from IMBCR / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 18, 2019

Alliance / Juno licenses IP from OncoTracker, Fred Hutchinson / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 8, 2017

Invitae Corp. / See Company Profile

Financing / Invitae nets $184.9mm in FOPO / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 8, 2019

Financing / Invitae nets $47mm via FOPO / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Apr. 2, 2018

Acquisition / Invitae acquires perinatal testing firm Good Start for $40mm / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

Exact Sciences Corp. / See Company Profile

Financing / Exact Sciences nets $634mm through upsized public notes offering / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 9, 2019

Acquisition / Exact Sciences buys sample prep firm Biomatrica / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 23, 2018

Alliance / Exact Sciences, Pfizer co-promote Cologuard / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 22, 2018


Pharmaceuticals

Email Alert | RSS Feed

Castle Creek Pharmaceuticals LLC / See Company Profile

Alliance / Castle Creek licenses US rights to Fibrocell's FCX007 RDEB gene therapy candidate for up to $135mm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 17, 2019

Alliance / Castle Creek licenses US rights to Hennig's Arlevert / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 16, 2016

Financing / Rare disease start-up Castle Creek brings in $48mm through early-stage round / Strategic Transactions / Deal Date: Oct. 1, 2016 / Publish Date: Oct. 7, 2016

Salix Pharmaceuticals Ltd. / See Company Profile

Alliance / Salix gets license to UCLA compound / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 4, 2019

Alliance / Salix to co-promote Doptelet with Dova / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Sep. 28, 2018

Alliance / Valeant gets US and Canadian license to Norgine's NER1006 / Strategic Transactions / Deal Date: Aug. 1, 2016 / Update Date: Sep. 1, 2018

Arteaus Therapeutics LLC / See Company Profile

Financing / Arteaus sells Emgality royalties to Royalty Pharma in $260mm financing / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 8, 2019

Alliance / Arteaus Therapeutics takes on Lilly’s migraine compound; Lilly later regains rights / Strategic Transactions / Deal Date: Oct. 1, 2011 / Update Date: Jan. 1, 2014

Financing / Series A round lands migraine-focused Arteaus Therapeutics $18mm / Strategic Transactions / Deal Date: Oct. 1, 2011 / Update Date: Jan. 1, 2014

Biotechnology

Biotechnology

Email Alert | RSS Feed

Rexahn Pharmaceuticals Inc. / See Company Profile

Alliance / BioSense Global to develop and sell Rexahn's RX3117 in Greater China / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 17, 2019

Financing / Public stock sale nets $8mm for Rexahn / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Feb. 9, 2019

Financing / Registered direct offering nets $7mm for Rexahn / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 23, 2018

Fibrocell Science Inc. / See Company Profile

Alliance / Castle Creek licenses US rights to Fibrocell's FCX007 RDEB gene therapy candidate for up to $135mm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 17, 2019

Financing / Fibrocell brings in $9.9mm through FOPO / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 19, 2017

Financing / Fibrocell nets $7.7mm through PIPE / Strategic Transactions / Deal Date: Mar. 1, 2017 / Publish Date: Mar. 14, 2017

PureTech Health PLC / See Company Profile

Alliance / BI, PureTech collaborate on I/O candidates in $226mm tie-up / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 18, 2019

Financing / Karuna brings in $68mm through its Series B round / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 19, 2019

Alliance / Purdue licenses Alivio's ALV107 for IC/BPS pain / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 31, 2019

IFM Tre / See Company Profile

Financing / IFM Tre launches with $31mm Series A round / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Apr. 4, 2019

Acquisition / Novartis acquires NLRP3 inflammasome-focused IFM Tre for up to $1.58bn / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 3, 2019

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Cerus Corp. / See Company Profile

Financing / Cerus signs debt facility for up to $90mm; $40mm drawn at closing / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 4, 2019

Financing / Cerus nets $57.2mm through public offering / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Feb. 3, 2018

Financing / Cerus receives $10mm debt financing from Oxford, amended / Strategic Transactions / Deal Date: Jul. 1, 2014 / Update Date: Aug. 1, 2017

Lantheus Holdings Inc. / See Company Profile

Alliance / Cerevast, Lantheus sign deal for retinal vein occlusion device / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 4, 2019

Alliance / Lantheus Medical, GE Healthcare enter preliminary agreement for PET cardiac imaging agent; deal finalized / Strategic Transactions / Deal Date: Feb. 1, 2017 / Update Date: Apr. 1, 2017

Financing / Lantheus Holdings nets $39.9mm via FOPO / Strategic Transactions / Deal Date: Sep. 1, 2016 / Publish Date: Sep. 22, 2016

PolarityTE Inc. / See Company Profile

Financing / Public offering brings in $24.9mm for PolarityTE / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 12, 2019

Financing / Latest follow-on grosses $58mm for PolarityTE / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 7, 2018

Financing / PolarityTE nets $35mm through public offering / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 16, 2018

Intrinsic Therapeutics Inc. / See Company Profile

Financing / Intrinsic raises $52mm via late-stage financing / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 15, 2019

Financing / Intrinsic closes financing of equity and debt / Strategic Transactions / Deal Date: May 1, 2017 / Publish Date: May 30, 2017

Financing / Intrinsic Therapeutics lands $12.25mm in late-stage round / Strategic Transactions / Deal Date: Oct. 1, 2012 / Publish Date: Nov. 26, 2012

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

Natera Inc. / See Company Profile

Financing / Public offering nets Natera $94mm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 22, 2019

Alliance / Natera to launch Signatera test in China on BGI's DNBseq NGS platform / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 12, 2019

Financing / Natera nets $84.6mm through FOPO / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 13, 2018

OncoTracker Inc. / See Company Profile

Alliance / OncoTracker licenses key patents from IMBCR / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 18, 2019

Alliance / Juno licenses IP from OncoTracker, Fred Hutchinson / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 8, 2017

Invitae Corp. / See Company Profile

Financing / Invitae nets $184.9mm in FOPO / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 8, 2019

Financing / Invitae nets $47mm via FOPO / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Apr. 2, 2018

Acquisition / Invitae acquires perinatal testing firm Good Start for $40mm / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

Exact Sciences Corp. / See Company Profile

Financing / Exact Sciences nets $634mm through upsized public notes offering / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 9, 2019

Acquisition / Exact Sciences buys sample prep firm Biomatrica / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 23, 2018

Alliance / Exact Sciences, Pfizer co-promote Cologuard / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 22, 2018

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Castle Creek Pharmaceuticals LLC / See Company Profile

Alliance / Castle Creek licenses US rights to Fibrocell's FCX007 RDEB gene therapy candidate for up to $135mm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 17, 2019

Alliance / Castle Creek licenses US rights to Hennig's Arlevert / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 16, 2016

Financing / Rare disease start-up Castle Creek brings in $48mm through early-stage round / Strategic Transactions / Deal Date: Oct. 1, 2016 / Publish Date: Oct. 7, 2016

Salix Pharmaceuticals Ltd. / See Company Profile

Alliance / Salix gets license to UCLA compound / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 4, 2019

Alliance / Salix to co-promote Doptelet with Dova / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Sep. 28, 2018

Alliance / Valeant gets US and Canadian license to Norgine's NER1006 / Strategic Transactions / Deal Date: Aug. 1, 2016 / Update Date: Sep. 1, 2018

Arteaus Therapeutics LLC / See Company Profile

Financing / Arteaus sells Emgality royalties to Royalty Pharma in $260mm financing / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 8, 2019

Alliance / Arteaus Therapeutics takes on Lilly’s migraine compound; Lilly later regains rights / Strategic Transactions / Deal Date: Oct. 1, 2011 / Update Date: Jan. 1, 2014

Financing / Series A round lands migraine-focused Arteaus Therapeutics $18mm / Strategic Transactions / Deal Date: Oct. 1, 2011 / Update Date: Jan. 1, 2014

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel